WVE

Wave Life Sciences (WVE)

About Wave Life Sciences (WVE)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Details

Daily high

$13.50

Daily low

$13.00

Price at open

$13.13

52 Week High

$21.73

52 Week Low

$5.28

Market cap

2.5B

Dividend yield

0.00%

Volume

2.7M

Avg. volume

3.8M

P/E ratio

-18.00

Wave Life Sciences News